Loading…
5 companies · GEL, thousands · columns ordered by revenue
| Line item | G.natadzis Sakhelobis S… | Kromosi | TL Medikal | Medlab 2024 | Medi Praim |
|---|---|---|---|---|---|
| Total Revenue | 1,907 | 1,844 | 1,769 | 1,766 | — |
| Total COGS | -163 | -495 | 0 | -632 | — |
| Gross Profit | 1,744 | 1,349 | 1,769 | 1,134 | — |
| Gross Margin | 91.5% | 73.2% | 100.0% | 64.2% | — |
| Total Operating Expenses | -1,340 | -605 | -1,552 | -473 | — |
| EBITDA | 405 | 745 | 218 | 660 | — |
| EBITDA Margin | 21.2% | 40.4% | 12.3% | 37.4% | — |
| Total D&A | -137 | -76 | -97 | -78 | — |
| EBIT / Operating Income | 268 | 668 | 121 | 582 | — |
| Total Interest Expense | -496 | -143 | — | — | — |
| Profit Before Tax | -228 | 537 | 298 | 586 | — |
| Total Income Tax | 0 | 0 | 0 | 0 | — |
| Net Profit / (Loss) | -228 | 537 | 209 | 586 | — |
| Net Margin | -12.0% | 29.1% | 11.8% | 33.2% | — |
| Total Other Income | — | 11 | 21 | 3 | — |
| Total Interest Income | — | — | 156 | — | — |
Not every picked company reports every selected year — FY2024: no filing for Medi Praim. Those cells are left blank (no filing), not zero.
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Kromosi | Healthcare Services | 40.4% | 95th pct | 268 |
| Medlab 2024 | Healthcare Services | 37.4% | 94th pct | 268 |
| G.natadzis Sakhelobis S… | Healthcare Services | 21.2% | 79th pct | 268 |
| TL Medikal | Healthcare Services | 12.3% | 56th pct | 268 |
| Medi Praim | Healthcare Services | — | no FY data | 268 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.